CD4 and Hodgkins lymphoma: However, our data suggest that stopping routine monitoring of CD4 counts would not be expected to result in diagnosis of Hodgkin lymphoma being missed or delayed if regular clinical-follow up is maintained, and clinicians are aware of the importance of monitoring for B symptoms, new palpable peripheral lymphadenopathy or abnormal blood biochemistry/cytopenias.